The COF-based PorSe-CuPt@CBL, preloaded with ZBP1 agonist CBL0137 under radiotherapy treatment, generates substantial amounts of ROS, which effectively trigger ZBP1-mediated PANoptosis and potentiate breast cancer treatment [88]. The gene discussed is ZBP1; the disease is breast carcinoma.